Correlation Between Cue Biopharma and Erasca

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Erasca at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Erasca into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and Erasca Inc, you can compare the effects of market volatilities on Cue Biopharma and Erasca and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Erasca. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Erasca.

Diversification Opportunities for Cue Biopharma and Erasca

-0.02
  Correlation Coefficient

Good diversification

The 3 months correlation between Cue and Erasca is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Erasca Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Erasca Inc and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Erasca. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Erasca Inc has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Erasca go up and down completely randomly.

Pair Corralation between Cue Biopharma and Erasca

Considering the 90-day investment horizon Cue Biopharma is expected to under-perform the Erasca. In addition to that, Cue Biopharma is 1.88 times more volatile than Erasca Inc. It trades about -0.01 of its total potential returns per unit of risk. Erasca Inc is currently generating about 0.06 per unit of volatility. If you would invest  185.00  in Erasca Inc on September 2, 2024 and sell it today you would earn a total of  101.00  from holding Erasca Inc or generate 54.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Cue Biopharma  vs.  Erasca Inc

 Performance 
       Timeline  
Cue Biopharma 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cue Biopharma are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Cue Biopharma exhibited solid returns over the last few months and may actually be approaching a breakup point.
Erasca Inc 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Erasca Inc are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Erasca may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Cue Biopharma and Erasca Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cue Biopharma and Erasca

The main advantage of trading using opposite Cue Biopharma and Erasca positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Erasca can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Erasca will offset losses from the drop in Erasca's long position.
The idea behind Cue Biopharma and Erasca Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Transaction History
View history of all your transactions and understand their impact on performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules